LncRNA MBNL1-AS1 represses gastric cancer progression via the TGF-β pathway by modulating miR-424-5p/Smad7 axis

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA. Cancer J Clinicians. 2018;68(6):394–424.
   Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. Global cancer statistics, CA. Cancer J Clinicians. 2011;61(2):69–90.
   Web of Science ®Google Scholar
• Pilleron S, Soto-perez-de-celis E, and Vignat J, et al. Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050. Int J Cancer. 2020;148(3): 601–608.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Zhang S, et al. Report of cancer incidence and mortality in China. Ann Transl Med. 2010;2(2014):1.
   Google Scholar
• Scartozzi M, Bittoni A, Pistelli M, et al. Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives. Cancer Treat Rev. 2009;35(5):451–462.
   PubMed Web of Science ®Google Scholar
• Kang Y-K, Boku N, Satoh T, et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390(10111):2461–2471.
   PubMed Web of Science ®Google Scholar
• Fashoyin-Aje L, Donoghue M, Chen H, et al. FDA Approval Summary: pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1. Oncologist. 2019;24(1):103–109.
   PubMed Web of Science ®Google Scholar
• Fitzgerald KA, Caffrey DR. Long noncoding RNAs in innate and adaptive immunity. Curr Opin Immunol. 2014;26:140–146.
   PubMed Web of Science ®Google Scholar
• Chandra Gupta, Y S, Nandan Tripathi Y. Nandan Tripathi, Potential of long non-coding RNAs in cancer patients: from biomarkers to therapeutic targets. Int J Cancer. 2017;140(9):1955–1967.
   PubMed Web of Science ®Google Scholar
• Jarroux J, Morillon, M A, Pinskaya M. Pinskaya, History, Discovery, and Classification of lncRNAs. Adv Exp Med Biol. 2017;1008:1–46.
   PubMed Web of Science ®Google Scholar
• Xie F, Liu Y-L, Chen X-Y, et al. Role of MicroRNA, LncRNA, and Exosomes in the Progression of Osteoarthritis: a Review of Recent Literature. Orthop Surg. 2020;12:708–716.
   PubMed Web of Science ®Google Scholar
• Court F, Baniol M, Hagege H, et al. Long-range chromatin interactions at the mouse Igf2/H19 locus reveal a novel paternally expressed long non-coding RNA. Nucleic Acids Res. 2011;39(14):5893–5906.
   PubMed Web of Science ®Google Scholar
• Xu C, Yang M, Tian J, et al. MALAT-1: a long non-coding RNA and its important 3’ end functional motif in colorectal cancer metastasis. Int J Oncol. 2011;39(1):169–175.
   PubMed Web of Science ®Google Scholar
• Jian F, Fuhao Q, Jingjing T, et al. High expression of long non-coding RNA NEAT1 indicates poor prognosis of human cancer. Oncotarget. 2017;8(28):45918–45927.
   PubMedGoogle Scholar
• Feng L, Zhu Y, and Zhang Y, et al., LncRNA GACAT3 promotes gastric cancer progression by negatively regulating miR-497 expression. Biomedicine & Pharmacotherapy. 2017;97:136–142.
   PubMed Web of Science ®Google Scholar
• Cao B, Liu C, Yang G. RETRACTED: down-regulation of lncRNA ADAMTS9-AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway. Biomed Pharmacothe. 2018;107:185–193.
   PubMed Web of Science ®Google Scholar
• Zhang H-M, Li H, Wang G-X, et al. MKL1/miR-5100/CAAP1 loop regulates autophagy and apoptosis in gastric cancer cells. Neoplasia. 2020;22(5):220–230.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang Z, Zhang W, et al. MicroRNAs play an essential role in autophagy regulation in various disease phenotypes. BioFactors. 2019;45(6):844–856.
   PubMed Web of Science ®Google Scholar
• Zhang Y-F, Li C-S, Zhou Y, et al. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer. Life Sci. 2020;244:117280.
   PubMed Web of Science ®Google Scholar
• Cao G, Tan B, Wei S, et al. Down-regulation of MBNL1-AS1 contributes to tumorigenesis of NSCLC via sponging miR-135a-5p. Biomed Pharmacother. 2020;125:109856.
   PubMed Web of Science ®Google Scholar
• Wei X, Wang B, Wang Q, et al. MiR-362-5p, Which Is Regulated by Long Non-Coding RNA MBNL1-AS1, Promotes the Cell Proliferation and Tumor Growth of Bladder Cancer by Targeting QKI. Front Pharmacol. 2020;11:164.
   PubMed Web of Science ®Google Scholar
• Chen D-L, Lu Y-X, Zhang J-X, et al. Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression. Theranostics. 2017;7(19):4836–4849.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang L, Wang Y, et al. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis. Biomed Pharmacother. 2019;109:1140–1147.
   PubMed Web of Science ®Google Scholar
• Gonzalez DM, and Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Science signaling. 2014;7(344):re8.
   PubMed Web of Science ®Google Scholar
• Slattery ML, Herrick J, Curtin K, et al. Increased Risk of Colon Cancer Associated with a Genetic Polymorphism of SMAD7. Cancer Res. 2010;70(4):1479–1485.
   PubMed Web of Science ®Google Scholar
• Bayoumi AS, Sayed A, Broskova Z, et al. Crosstalk between Long Noncoding RNAs and MicroRNAs in Health and Disease. Int J Mol Sci. 2016;17(3):356.
   PubMed Web of Science ®Google Scholar
• Cao G, Tan B, Wei S, et al. Down-regulation of MBNL1-AS1 contributes to tumorigenesis of NSCLC via sponging miR-135a-5p. Biomed Pharmacother. 2020;125:109856.
   PubMed Web of Science ®Google Scholar
• Wei X, Yang X, Wang B, et al. LncRNA MBNL 1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer. Cancer Med. 2020;9(2):724–736.
   PubMed Web of Science ®Google Scholar
• Liu W, Lin W, Yu L. Long non-coding RNA muscleblind like splicing regulator 1 antisense RNA 1 (LncRNA MBNL1-AS1) promotes the progression of acute myocardial infarction by regulating the microRNA-132-3p/SRY-related high-mobility-group box 4 (SOX4) axis. Bioengineered. 2022;13(1):1424–1435.
   PubMed Web of Science ®Google Scholar
• Cheng L, Zhang C, Li D, et al. Transforming Growth Factor-β1 (TGF-β1) Induces Mouse Precartilaginous Stem Cell Proliferation through TGF-β Receptor II (TGFRII)-Akt-β-Catenin Signaling. Int J Mol Sci. 2014;15(7):12665–12676.
   PubMed Web of Science ®Google Scholar
• Massague J. The TGF-β family of growth and differentiation factors. Cell. 1987;49(4):437–438.
   PubMed Web of Science ®Google Scholar
• Muraoka RS, Dumont N, Ritter CA, et al. Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases. J Clin Invest. 2002;109(12):1551–1559.
   PubMed Web of Science ®Google Scholar
• Suzuki HI, Kiyono K, Miyazono K. Regulation of autophagy by transforming growth factor-β (TGF-β) signaling. Autophagy. 2010;6(5):645–647.
   PubMed Web of Science ®Google Scholar
• Guo Q, Betts C, Pennock N, et al. Mammary Gland Involution Provides a Unique Model to Study the TGF-β Cancer Paradox. J Clin Med. 2017;6(1):10.
   PubMed Web of Science ®Google Scholar
• Katsuno Y, Lamouille S, Derynck R. TGF-β signaling and epithelial–mesenchymal transition in cancer progression. Curr Opin Oncol. 2013;25(1):76–84.
   PubMed Web of Science ®Google Scholar
• Levy L, Hill CS. Alterations in components of the TGF-β superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev. 2006;17(1–2):41–58.
   PubMed Web of Science ®Google Scholar
• McPherson JM. p53/TGF-β/cancer: an intriguing connection. Cytokine Growth Factor Rev. 1996;7(4):295.
   PubMedGoogle Scholar
• Meulmeester E, Ten Dijke P. The dynamic roles of TGF-β in cancer. J Pathol. 2011;223(2):205–218.
   PubMed Web of Science ®Google Scholar
• Chung ACK, Dong Y, Yang W, et al. Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs. Mol Ther. 2013;21(2):388–398.
   PubMed Web of Science ®Google Scholar
• Zhao J, Crowe DL, Castillo C, et al. Smad7 is a TGF-β-inducible attenuator of Smad2/3-mediated inhibition of embryonic lung morphogenesis. Mech Dev. 2000;93(1–2):71–81.
   PubMed Web of Science ®Google Scholar